# Medical marijuana for management of cancer pain: a narrative review. > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/medical-marijuana-cancer-pain-management-review-2025/ > **Published:** 2026-04-26T22:25:09-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:54:38-04:00 > **Clinical Summary:** Explore the 2025 narrative review on medical marijuana cancer pain management, highlighting current evidence and clinical insights. --- CED Clinical Relevance  #100High Clinical Relevance Evidence Brief | CED ClinicNarrative review examines medical marijuana efficacy for [cancer pain management](https://cedclinic.com/medical-cannabis-safety-efficacy-cancer-study/) across 40 US states with legal access. Cancer PainMedical MarijuanaNarrative ReviewOncologyPain Management Narrative review examines medical marijuana efficacy for [cancer pain management](https://cedclinic.com/medical-cannabis-safety-efficacy-cancer-study/) across 40 US states with legal access. What This Study Teaches Us This narrative review consolidates recent evidence on medical marijuana use for cancer pain across the expanding legal landscape in the US. The systematic approach to literature synthesis helps clarify current understanding of cannabis efficacy and usage patterns in oncology pain management. Why This Matters With 40 states now permitting medical marijuana, oncologists and pain specialists need evidence-based guidance on cannabis integration into cancer care. This review addresses the growing clinical need for synthesized data on marijuana’s role in comprehensive cancer pain management strategies. Study Snapshot Study Type Narrative Review Population Cancer patients using medical marijuana for pain management Intervention Medical marijuana/cannabis products Comparator Not applicable for narrative review Primary Outcome Prevalence and efficacy of marijuana use for cancer-related pain Key Finding Review synthesis of cannabis use patterns and effectiveness in cancer pain (specific results not provided in abstract) Journal Annals of Palliative Medicine Year 2025 Clinical Bottom Line The review provides a structured examination of medical marijuana’s role in cancer pain management within the current legal framework. However, without access to the full synthesis results, specific clinical recommendations cannot be extracted from this abstract alone. What This Paper Does Not Show The abstract does not present the actual findings, effect sizes, or specific recommendations from the reviewed literature. It cannot establish causation, optimal dosing protocols, or comparative effectiveness against standard cancer pain treatments. Where This Paper Deserves Skepticism Narrative reviews lack the systematic methodology of meta-analyses and may be subject to selection bias in included studies. The variability in cannabis products, dosing, and patient populations across reviewed studies likely limits generalizable conclusions. Dr. Caplan's Take I see narrative reviews as valuable for mapping the landscape of [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) in oncology, but they require careful interpretation. The abstract suggests this covers recent literature, which is helpful given the rapidly evolving legal and clinical context, but I need to see the actual synthesis to assess clinical utility. What a Careful Reader Should Take Away This review represents an attempt to systematically examine cannabis use in cancer pain management within the current US legal framework. The clinical value depends entirely on the quality of the synthesis and specific findings, which are not available in this abstract. Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Medical%20marijuana%20for%20management%20of%20cancer%20pain%3A%20a%20narrative%20review.%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2Fmedical-marijuana-cancer-pain-management-review-2025%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fmedical-marijuana-cancer-pain-management-review-2025%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Medical%20marijuana%20for%20management%20of%20cancer%20pain%3A%20a%20narrative%20review.%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2Fmedical-marijuana-cancer-pain-management-review-2025%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) Table of Contents - [FAQ](#FAQ)[Is medical marijuana legal for cancer pain management in the United States?](#Is_medical_marijuana_legal_for_cancer_pain_management_in_the_United_States) - [How effective is medical marijuana for treating cancer-related pain?](#How_effective_is_medical_marijuana_for_treating_cancer-related_pain) - [What types of cannabinoids are being studied for cancer pain relief?](#What_types_of_cannabinoids_are_being_studied_for_cancer_pain_relief) - [Why do patients respond differently to medical marijuana for cancer pain?](#Why_do_patients_respond_differently_to_medical_marijuana_for_cancer_pain) - [What should oncologists know about prescribing medical marijuana for cancer patients?](#What_should_oncologists_know_about_prescribing_medical_marijuana_for_cancer_patients) - [Related](#Related) ## FAQ #### Is medical marijuana legal for cancer pain management in the United States? Yes, medical marijuana is currently legal in 40 states and the District of Columbia. This widespread legalization has increased clinical interest in its application for managing cancer-related pain, though regulations and access vary by state. #### How effective is medical marijuana for treating cancer-related pain? This narrative review examined the efficacy of medical marijuana for cancer pain management, though specific efficacy data would need to be extracted from the individual studies analyzed. The review focuses on understanding both the therapeutic effects and the variability in patient responses to [cannabis-based treatments](https://cedclinic.com/cannabis-medical-clinic-experience-beyond-smoking-vaping/). #### What types of cannabinoids are being studied for cancer pain relief? The research encompasses various cannabinoids including THC (tetrahydrocannabinol) and CBD (cannabidiol), as well as broader medical cannabis formulations. These different compounds may have varying effects on pain pathways and patient outcomes in oncology settings. #### Why do patients respond differently to medical marijuana for cancer pain? Patient response variability remains a key area of investigation in [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/). Factors contributing to different responses may include individual pain pathway differences, cancer type, dosing protocols, and genetic variations in [cannabinoid metabolism](https://cedclinic.com/fatty-acid-amide-hydrolase-obesity-risk-genetic-links/), though more research is needed to fully understand these mechanisms. #### What should oncologists know about prescribing medical marijuana for cancer patients? Oncologists should be aware that while medical marijuana shows promise for cancer pain management, the evidence base is still developing. Understanding local legal requirements, potential drug interactions, and individual patient factors is essential before considering [cannabis-based treatments](https://cedclinic.com/cannabis-medical-clinic-experience-beyond-smoking-vaping/) as part of a comprehensive pain management strategy. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Medical Marijuana: Delivering Clinical Care in an Ever-Evolving Environment Event Details](https://cedclinic.com/medical-marijuana-delivering-clinical-care-in-an-ever-evolving-environment-event-details/) Explore clinical care strategies for medical marijuana in evolving healthcare settings. [Learn More](https://cedclinic.com/medical-marijuana-delivering-clinical-care-in-an-ever-evolving-environment-event-details/) [Cannabinoids in Pediatric Medicine: Evidence-Based Care and Emerging Research](https://cedclinic.com/cannabinoids-pediatric-clinical-evidence-review/) Review emerging research on cannabinoids in pediatric medicine and evidence-based care. [Read Article](https://cedclinic.com/cannabinoids-pediatric-clinical-evidence-review/) [CBD Reviews: Benefits, Efficacy, and Product Analysis for Informed Choices](https://cedclinic.com/cbd-product-evaluation-challenges-clinical-insights-guidance/) Detailed analysis of [CBD products](https://cedclinic.com/fda-warning-on-cbd-products/) focusing on benefits and clinical efficacy. [Explore Reviews](https://cedclinic.com/cbd-product-evaluation-challenges-clinical-insights-guidance/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).